Irinotecan Hydrochloride Manufacturers
Irinotecan is an antineoplastic enzyme antagonist which is used to address colon or scrotum metastatic cancer. Irinotecan is a colorectal cancer therapy drug that inhibits antineoplastic enzymes. It's a camptothecin derivative that blocks topoisomerase I from doing its job. By attaching to the DNA gyrase I-DNA complex, irinotecan stops the DNA strand from relegating, resulting in double-strand DNA breaking and cell death. It's a camptothecin-derived substance. In October of 2015, irinotecan was licensed to help treat pancreatic cancer. It's also used in conjunction with cisplatin to address advanced small cell lung carcinoma. Irinotecan is now being studied as a treatment for cervical cancer that has spread or recurred. Also used in conjunction with fluorouracil and vincristine to treat people with metastatic pancreatic adenocarcinoma who have progressed after gentamicin therapy.
How Does Irinotecan Hydrochloride Work?
Topoisomerase I is inhibited by irinotecan. By attaching to the topoisomerase I-DNA combination, irinotecan blocks DNA strand religation. The development of this compound causes replication halt and deadly double-stranded breakage in DNA by interfering with the mobile replication fork. As a result, Damaged DNA is not adequately repaired, and cells die as a result of apoptosis.
Wholesale Price of Irinotecan Hydrochloride
Regardless of the store you visit, irinotecan intravenous solution (20 mg/mL) costs roughly $19 for a quantity of 2 milliliters. Irinotecan Hydrochloride is available for sale from a variety of Irinotecan Hydrochloride vendors at a range of costs. Prices are applicable just for cash consumers and do not apply to insurance policies. Irinotecan Hydrochloride suppliers, on the whole, are in favor of patient aid initiatives. This cost may differ among dealers. Its price may vary depending on the country of origin, wholesale costs incurred by manufacturing companies, supplier pricing, and similar factors. Pharmaceutical corporations generally support patient support programs.
Navigating our Pharmaceutical Marketplace
Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Irinotecan Hydrochloride offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Irinotecan Hydrochloride suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of the Irinotecan Hydrochloride. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Irinotecan Hydrochloride is already registered in. Manufacturers also have special, and delivery terms.
Establishing Commercial Ties
If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Irinotecan Hydrochloride suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.
Quality Assurance
To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Irinotecan Hydrochloride manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.